Koninklijke Philips | PHG - Des Atouts





Des Atouts Changement Date
Abbott USD 110.43B 23.72B 2026-03
Baxter International USD 19.79B 55M 2026-06
Becton, Dickinson and Co. USD 50.73B 101M 2026-06
Boston Scientific USD 45.22B 865M 2026-06
Danaher USD 92.37B 8.82B 2026-06
Demant DKK 40.03B 951M 2026-06
Dexcom USD 6.46B 178M 2026-06
Edwards Lifesciences USD 13.87B 545.9M 2026-06
Fresenius EUR 41.84B 526M 2026-06
General Electric Aerospace USD 127.67B 773M 2026-06
Getinge SEK 57.37B 6.55B 2026-06
Globus Medical USD 5.49B 48.7M 2026-06
GN Store Nord DKK 29.55B 996M 2026-06
Hitachi JPY 15.04T 164M 2026-06
Idexx Laboratories USD 3.44B 56.84M 2026-06
Insulet USD 3.17B 177.9M 2026-06
Integra LifeSciences USD 3.56B 14.24M 2026-06
Intuitive Surgical USD 20.88B 765.6M 2026-06
J&J USD 201.06B 167M 2026-06
Koninklijke Philips EUR 27.27B 4.38B 2026-03
Medtronic USD 93.31B 278M 2026-06
Philips EUR 26.7B 565M 2026-06
ResMed USD 8.97B 181.66M 2026-06
Smith & Nephew USD 11.01B 321M 2026-06
Steris USD 10.74B 1.1M 2026-06
Stryker USD 47.93B 1.64B 2026-06
Teleflex USD 6.79B 3.78M 2026-06
Terumo JPY 2.37T 61.86B 2026-06
Zimmer Biomet Holdings USD 22.8B 76.2M 2026-06